An NU610 Unit 9 analysis of one incidental 7 mm lung nodule in a composite nonsmoker, setting its follow-up by the Fleischner criteria and closing the loop an emergency visit opened. Searches like "nu 610 unit 9 assignment example", "nu610 unit 9 sample" and "nu610 unit 9 example" land here.
A Seven-Millimeter Nodule on a Negative Pulmonary Embolism Scan: An Incidental Finding Analysis Under the 2017 Fleischner Guidelines
[Student Name]
Purdue University Global
NU610: NP III Clinical - Primary Care Focus
Unit 9 Incidental Finding Analysis
[Instructor Name]
[Date]
The patient is composite; the report wording, dates and measurements are bracketed and paraphrased rather than taken from a real report.
Part One: The Finding and Its Context
The report, as paraphrased from the radiologist: "No pulmonary embolism. Incidental [7 mm] solid nodule in the right upper lobe, [image number]. Recommend follow-up per Fleischner Society guidelines." The CT pulmonary angiogram was ordered in the emergency department on [date] for [pleuritic chest pain after a long drive], and the negative result for embolism ended that question. The nodule is a second question the scan was not asked.
Context, organized by the factors the guideline uses:
1. Age: [43].
2. Smoking: never smoked; no regular exposure to secondhand smoke at home or work.
3. Occupational and environmental exposures: [office work]; no asbestos, silica, radon testing unknown.
4. Family history: no lung cancer in first-degree relatives.
5. Cancer history: none.
6. Immune status: not immunocompromised.
7. Nodule: single, solid, [7 mm] average diameter, smooth margins as reported, right upper lobe.
8. Prior imaging: none available for comparison.
Part Two: Risk Assignment
The guideline groups patients into low and high risk using clinical factors, including smoking history, exposures and family history, and nodule factors such as size, margins and upper-lobe location (MacMahon et al., 2017). By clinical factors he is low risk: a lifelong nonsmoker in his forties without exposures or family history. The nodule is small and smoothly marginated.
One feature points upward. Upper-lobe location is associated with a higher likelihood of malignancy in nodule risk models, which is why it appears in the guideline's list (Gould et al., 2013). It does not by itself move him into the high-risk group, but it is the reason this analysis does not treat the nodule as trivial.
For a single solid nodule of this size, the low-risk and high-risk schedules begin with the same step, so today's decision does not depend on getting the classification exactly right. The difference between the two schedules comes later, at the question of a second scan.
Part Three: Applying the Guideline
For a single solid nodule of 6 to 8 mm, the 2017 Fleischner guidelines recommend CT at 6 to 12 months for both low-risk and high-risk patients. For low-risk patients, they then advise considering CT at 18 to 24 months; for high-risk patients, CT at 18 to 24 months is recommended (MacMahon et al., 2017). Given the upper-lobe location, I would plan to proceed to the 18 to 24 month scan unless the first follow-up shows the nodule has resolved or clearly shrunk, which is a reasonable use of the "consider" wording.
The guidelines have stated exclusions. They are not meant for anyone younger than 35, for people with a cancer elsewhere that could have spread to the lung, to immunocompromised patients at risk of infection, or to people in lung cancer screening programs, who are managed with a separate reporting system (MacMahon et al., 2017). He is [43], has no cancer history, is not immunocompromised and is not in a screening program. He also does not meet screening eligibility, which requires age 50 to 80 and a substantial smoking history (US Preventive Services Task Force, 2021). The Fleischner recommendation therefore applies to him directly.
Tests Not Ordered
PET-CT: at 7 mm, a nodule is below the size at which PET is reliable, and the guideline does not recommend it for solid nodules under 8 mm. Biopsy: not indicated at this size and risk; the nodule is too small for reliable sampling and the likelihood of malignancy is low. Immediate pulmonology referral: not needed for a nodule managed with surveillance imaging, though it would follow if the nodule grows. Repeat CT sooner than 6 months: not recommended; growth in a benign nodule is unlikely to be seen, and an early scan adds radiation without changing management.
Part Four: The Follow-Up Plan
Who told him: [writer], by phone on [date], [three] days after the emergency visit, with the collaborating physician aware. What he was told: the scan found no clot; it also showed a small spot in the right lung, which is very likely harmless in someone with his history, but which needs one or two follow-up scans to confirm it is not changing. He asked whether it could be cancer; told that the chance is low and that the scans are how we make sure. When the scan is due: noncontrast chest CT booked for [month and year], within the 6 to 12 month window. The tracking step: an entry in the practice's incidental findings list, with an alert set for [two weeks] after the due date if no report has been received, prompting a call to the patient and the imaging center. After the first scan: the result is reviewed, the decision on the 18 to 24 month scan is recorded, and the patient is told the plan.
The analysis ends with a limit. Incidental findings are often lost between emergency departments and primary care, and a plan without a tracking step is a plan that relies on memory. Here the tracking step is what turns a recommendation into a scan that happens.
References
Gould, M. K., Donington, J., Lynch, W. R., Mazzone, P. J., Midthun, D. E., Naidich, D. P., & Wiener, R. S. (2013). Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5 Suppl.), e93S-e120S. https://doi.org/10.1378/chest.12-2351
MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., Rubin, G. D., Schaefer-Prokop, C. M., Travis, W. D., Van Schil, P. E., & Bankier, A. A. (2017). Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology, 284(1), 228-243. https://doi.org/10.1148/radiol.2017161659
US Preventive Services Task Force. (2021). Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA, 325(10), 962-970. https://doi.org/10.1001/jama.2021.1117
How this NU610 Unit 9 example is structured
The analysis opens with the finding in the radiologist's own words, because interpretation begins with what was actually reported. Context follows, organized as the risk factors the guideline uses: age, smoking, exposures, family history, nodule size, morphology and location. The risk assignment section weighs those factors and admits the one that points upward. Its key observation is that the low-risk and high-risk schedules share the same first step for a nodule of this size, so the immediate decision does not hinge on the classification. Next, the Fleischner recommendation is quoted along with its exclusions, including patients under 35 and lung cancer screening populations, to show that the guideline applies here. A section on tests not ordered follows. The plan section names who told the patient, when the scan is due, and what the tracking step does if it is missed.
Get an NU610 Unit 9 example written to your instructions
Paste the Unit 9 finding exactly as your NU610 case reports it, along with the patient context and the rubric. An analysis written from those returns within 24-48h, at no charge on a first request, quoting the report, weighing each risk factor the relevant guideline uses, choosing the matching follow-up row, and naming who owns the loop from here. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
NU610 Unit 9 questions, answered
Which guideline applies to an incidental finding?
The one written for that organ and that type of finding: Fleischner for incidental lung nodules in adults, the ACR incidental findings white papers for many abdominal findings, and thyroid-specific systems for thyroid nodules. Check each guideline's stated exclusions before applying it, since a screening population or a patient with known cancer usually falls outside it.
Should the analysis follow the radiologist's recommendation?
Usually, if it matches the guideline. Where it differs, name both, explain the discrepancy, and say which one the plan adopts. Radiologists sometimes recommend follow-up that is more or less intensive than the guideline for reasons visible in the images, so a phone call or an addendum request can be part of a good plan.
Who is responsible for following up a finding from an emergency visit?
In most systems, the primary care clinician who receives the report, unless the emergency team explicitly arranged follow-up. The analysis should say who told the patient and who holds the tracking task. Findings discovered in one setting and owned in another are a classic source of missed follow-up, which is why graders look for named ownership.